From a global perspective, the large and diverse African population is disproportionately
affected by cardiovascular disease (CVD). The historical balance between communicable …

Human immunodeficiency virus (HIV)-associated heart disease encompasses a broad
spectrum of diseases. HIV infection may involve the pericardium, myocardium, coronary …

Aims To describe the outcomes of pregnancy in women with pulmonary hypertension.
Methods and results In 2007 the European Registry on Pregnancy and Heart Disease was …

Background Epidemiology, aetiology, management and outcome data for various forms of
pulmonary hypertension (PH) in Africa are scarce. Methods A prospective, multinational …

The epidemiology of pulmonary hypertension (PH) is not fully determined worldwide but is
believed to vary in different regions of the world, with differences determined by genetic …

Background Studies from high income countries report that HIV-positive people have an
impaired systolic and diastolic cardiac function compared to HIV-negative people. It is …

Pulmonary hypertension (PH) is a devastating, progressive disease with increasingly
debilitating symptoms and usually shortened overall life expectancy. This article reviews the …

Background Despite the recent increasing worldwide attention towards pulmonary
hypertension (PH), its epidemiology remains poorly described in Africa. Accordingly, we …

Objective Patients infected with HIV have a direly increased risk of developing pulmonary
hypertension (PH), and of dying from the condition. While Africa carries the greatest burden …

Background Data characterizing risk factors and long-term outcome studies on human
immunodeficiency virus (HIV)-associated pulmonary hypertension (PH) in Africa are lacking …